These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26939581)

  • 21. Acinetobacter baumannii NCIMB8209: a Rare Environmental Strain Displaying Extensive Insertion Sequence-Mediated Genome Remodeling Resulting in the Loss of Exposed Cell Structures and Defensive Mechanisms.
    Repizo GD; Espariz M; Seravalle JL; Díaz Miloslavich JI; Steimbrüch BA; Shuman HA; Viale AM
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32727858
    [No Abstract]   [Full Text] [Related]  

  • 22. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
    Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
    J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic resistance determinants of multidrug-resistant Acinetobacter baumannii clinical isolates in Algeria.
    Bakour S; Touati A; Sahli F; Ameur AA; Haouchine D; Rolain JM
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):529-31. PubMed ID: 23688522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant
    Mujawar S; Mishra R; Pawar S; Gatherer D; Lahiri C
    Front Cell Infect Microbiol; 2019; 9():203. PubMed ID: 31281799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity.
    Imperi F; Antunes LC; Blom J; Villa L; Iacono M; Visca P; Carattoli A
    IUBMB Life; 2011 Dec; 63(12):1068-74. PubMed ID: 22034231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.
    Bonnin RA; Nordmann P; Poirel L
    Expert Rev Anti Infect Ther; 2013 Jun; 11(6):571-83. PubMed ID: 23750729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Confronting multidrug-resistant Acinetobacter baumannii: a review.
    Neonakis IK; Spandidos DA; Petinaki E
    Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
    Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
    Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete genome sequence of Acinetobacter baumannii MDR-TJ and insights into its mechanism of antibiotic resistance.
    Huang H; Yang ZL; Wu XM; Wang Y; Liu YJ; Luo H; Lv X; Gan YR; Song SD; Gao F
    J Antimicrob Chemother; 2012 Dec; 67(12):2825-32. PubMed ID: 22952140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals.
    Al-Sweih NA; Al-Hubail MA; Rotimi VO
    J Chemother; 2011 Feb; 23(1):13-6. PubMed ID: 21482488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan.
    Chang KC; Lin MF; Lin NT; Wu WJ; Kuo HY; Lin TY; Yang TL; Chen YC; Liou ML
    J Microbiol Immunol Infect; 2012 Feb; 45(1):37-42. PubMed ID: 22154678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii ST2 Clinical Isolate in Algeria: First Case Report.
    Bakour S; Olaitan AO; Ammari H; Touati A; Saoudi S; Saoudi K; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):279-85. PubMed ID: 25588125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
    Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
    J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
    Cai Y; Chai D; Wang R; Liang B; Bai N
    J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.
    Jiang W; Liu H; Zhong M; Yang YC; Xiao DW; Huang WF
    Microb Drug Resist; 2013 Apr; 19(2):117-23. PubMed ID: 22845773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.